Naproxen
NDC 21130-062, Naproxen, tablet, from Safeway, Inc.
- Product NDC
- 21130-062
- Status
- Listed
- Labeler
- Safeway, Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA091353
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/21130-062 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 21130-062-05 | 21130006205 | 50 TABLET in 1 BOTTLE (21130-062-05) |
| 21130-062-09 | 21130006209 | 90 TABLET in 1 BOTTLE (21130-062-09) |
| 21130-062-20 | 21130006220 | 200 TABLET in 1 BOTTLE (21130-062-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 21130-062 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/21130-062 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 21130-062. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.